Investigating the efficacy of baricitinib in new onset type 1 diabetes mellitus (BANDIT)-study protocol for a phase 2, randomized, placebo controlled trial.
M WaibelH E ThomasJ M WentworthJ J CouperR J MacIsaacF J CameronM SoB KrishnamurthyM C DoyleThomas W H KayPublished in: Trials (2022)
gov NCT04774224. Registered on 01 March 2021.